Clinical trial
A Phase 2b Study to Evaluate the Efficacy and Safety of Mavrilimumab in Subjects with Moderate-to-Severe Rheumatoid Arthritis.
To evaluate the efficacy of mavrilimumab in subjects with moderate-to-severe adult onset RA.
| Category | Value |
|---|---|
| Study start date | 2012-04-11 |